CG Oncology CGON Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about CG Oncology's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CG Oncology's shares (diluted)?
- CG Oncology (CGON) reported shares (diluted) of 84.5M in Q1 2026.
- How has CG Oncology's shares (diluted) changed year-over-year?
- CG Oncology's shares (diluted) increased by 10.9% year-over-year, from 76.2M to 84.5M.
- What is the long-term trend for CG Oncology's shares (diluted)?
- Over 2 years (2023 to 2025), CG Oncology's shares (diluted) has grown at a 331.1% compound annual growth rate (CAGR), from 16.5M to 306.4M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.